Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
65°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about RNA
Recent news which mentions RNA
< Previous
1
2
3
4
5
Next >
Avidity (RNA) Q2 Revenue Jumps 88%
August 07, 2025
Tickers
RNA
Tags
RNA
Market News
Recent Press Releases
From
Motley Fool
Veritex Holdings, Sequans Communications, Canaan And Other Big Stocks Moving Higher On Monday
July 14, 2025
Tickers
CAN
DEFT
IREN
MARA
Tags
MARA
Intraday Update
CAN
From
Benzinga
Expert Outlook: Avidity Biosciences Through The Eyes Of 11 Analysts
June 27, 2025
Tickers
RNA
Tags
Analyst Ratings
Benzinga
BZI/AAR
From
Benzinga
The Analyst Verdict: Avidity Biosciences In The Eyes Of 12 Experts
June 10, 2025
Tickers
RNA
Tags
RNA
Market News
Benzinga
From
Benzinga
Avidity Biosciences Touts Encouraging Functional Gains And Biomarker Reductions In Rare Muscular Weakness Disease Trial
June 09, 2025
Tickers
NEWS
RNA
Tags
General
Top Stories
Stories That Matter
From
Benzinga
12 Analysts Assess Avidity Biosciences: What You Need To Know
May 07, 2025
Tickers
RNA
Tags
RNA
Benzinga
BZI/AAR
From
Benzinga
Beyond The Numbers: 13 Analysts Discuss Avidity Biosciences Stock
April 09, 2025
Tickers
RNA
Tags
RNA
Analyst Ratings
Benzinga
From
Benzinga
Forecasting The Future: 13 Analyst Projections For Avidity Biosciences
March 18, 2025
Tickers
RNA
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
Avidity Biosciences Touts Positive Data From Early-Stage Duchenne Muscular Dystrophy Study Data, FDA Submission Expected By End Of 2025
March 17, 2025
Tickers
NEWS
RNA
Tags
Market News
Health Care
Movers
From
Benzinga
Dyne Therapeutics' $4.3 Billion Peak Sales Potential? Analyst Highlights Key Strengths And Risks
March 12, 2025
Tickers
DYN
NEWS
RNA
Tags
Initiation
Market News
Analyst Color
From
Benzinga
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
March 12, 2025
Tickers
NEWS
RADX
RNA
SPGI
Tags
UPWK
Analyst Ratings
Markets
From
Benzinga
Avidity Biosciences Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
February 28, 2025
Tickers
RNA
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
Analyst Expectations For Avidity Biosciences's Future
January 10, 2025
Tickers
RNA
Tags
Market News
Analyst Ratings
BZI/AAR
From
Benzinga
Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic
January 03, 2025
Tickers
ALNY
BIIB
DNLI
IONS
Tags
Health Care
RNA
Trading Ideas
From
Benzinga
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
December 20, 2024
Tickers
FICO
MNKD
NEWS
PRTA
Tags
Market News
Initiation
SPGI
From
Benzinga
What 8 Analyst Ratings Have To Say About Avidity Biosciences
December 20, 2024
Tickers
RNA
Tags
Analyst Ratings
BZI/AAR
Benzinga
From
Benzinga
Assessing Avidity Biosciences: Insights From 10 Financial Analysts
November 13, 2024
Tickers
RNA
Tags
Analyst Ratings
BZI/AAR
Benzinga
From
Benzinga
In-Depth Examination Of 10 Analyst Recommendations For Avidity Biosciences
October 21, 2024
Tickers
RNA
Tags
Market News
Benzinga
BZI/AAR
From
Benzinga
Evaluating Avidity Biosciences: Insights From 10 Financial Analysts
October 21, 2024
Tickers
RNA
Tags
RNA
Market News
BZI/AAR
From
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 07, 2024
Tickers
CUE
IMNM
KAPA
LGMK
Tags
MYNZ
Market News
TRVN
From
Benzinga
Why Avidity Biosciences Zoomed to a 12% Gain This Week
October 04, 2024
Tickers
GS
RNA
Tags
RNA
GS
Recent Press Releases
From
Motley Fool
Goldman Sachs Bullish On Avidity Biosciences, Cites Scalable RNA Therapeutics Platform For Rare Diseases
September 24, 2024
Tickers
NEWS
RNA
Tags
General
Analyst Ratings
Stories That Matter
From
Benzinga
Unveiling 7 Analyst Insights On Avidity Biosciences
September 16, 2024
Tickers
RNA
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
September 09, 2024
Tickers
FULC
NEWS
RHHBY
RNA
Tags
Trading Ideas
FULC
RHHBY
From
Benzinga
Deep Dive Into Avidity Biosciences Stock: Analyst Perspectives (10 Ratings)
August 28, 2024
Tickers
RNA
Tags
RNA
Analyst Ratings
Benzinga
From
Benzinga
The Analyst Landscape: 7 Takes On Avidity Biosciences
August 12, 2024
Tickers
RNA
Tags
Analyst Ratings
Benzinga
BZI/AAR
From
Benzinga
RNA Stock Earnings: Avidity Biosciences Beats EPS, Misses Revenue for Q2 2024
August 09, 2024
Tickers
RNA
Tags
Market News
Earnings Reports
NASDAQ:RNA
From
InvestorPlace
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
August 09, 2024
Tickers
ADMA
AKAM
BLND
CARG
Tags
G
Markets
Market News
From
Benzinga
3 Stocks Doing Even Better Than Superstar Super Micro (SMCI)
July 24, 2024
Tickers
AMZN
JMIA
MSTR
NVDA
Tags
AMZN
BTC/USD
SMCI
From
InvestorPlace
3 Russell 2000 Growth Stocks That Could Be Worth the Risk
July 23, 2024
Tickers
LBPH
RNA
SOUN
Tags
Recent Press Releases
Market News
SOUN
From
Motley Fool
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
